AdvaMed launched a pilot program at AngioDynamics' headquarters in New York to educate medtech employees about the 2.3% medical device tax and other policies affecting the industry. "[I]f this goes well, this will be a prototype for how we work within other device companies to educate and engage," said AngioDynamics President and CEO Joseph DeVivo, who is also a member of AdvaMed's board.

Related Summaries